
    
      All nondiabetic patients with dysglycemia (fasting plasma glucose between 100 and 125 mg/dl)
      will be monitored with a device (Continuous Glucose Monitoring System) and all these patients
      will be undergone an oral glucose tolerance test after the discharge from this Unit.
    
  